Don Gabriel, M.D., Ph.D Medical Director
Dr. Gabriel was a Professor of Medicine at the University of North Carolina (UNC) at Chapel Hill, where he was a hematologist and bone marrow transplant physician for more than thirty years. He also served as Associate Chief of Staff, Assistant Dean for Clinical Services, Acting Chief of Medical Oncology, and Service Chief Liaison of the Division of Hematology/Oncology at UNC. His areas of expertise include oncology, hematology, and the application of physical methods such as light scattering to hemostasis and hematology.
Dr. Gabriel Received his MD from UNC as well as a PhD in Biophysical Chemistry. He completed an internal medicine residency at Massachusetts General Hospital, a Fellowship in Hematology at UNC and a stem cell transplant fellowship at the Fred Hutchinson Cancer Center in Seattle. He was a recipient of the Lineberger Cancer Center Distinguished Achievement Award. Dr. Gabriel has served as co- or principal investigator numerous clinical trials.
In addition, Dr. Gabriel has served as a clinical consultant to many leading pharmaceutical companies and is a founder of Invitrox.
Weslyn Friley, Ph.D Director of Bioanalytical
Weslyn brings over 13 years of experience working and managing operations in the field of bioanalysis, as well as ADME and DMPK programs and has experience in working in GLP, GCLP and CLIA regulated environments.
Prior to joining Invitrox, Weslyn was responsible for and managed the analytical services operations at Qualyst Transporter Solutions. At Qualyst, Weslyn provided operational and technical support for bioanalytical aspects of the design and development of in vitro drug-drug interaction studies to answer client specific questions for their compounds. Weslyn also served on the Research and Development Committee at Qualyst for the development of new products and services in support of in vitro models for drug development, natural products, and chemical toxicology.
As a senior project manager at Tandem Labs, Weslyn was responsible for overall management and conduct of Clinical, CLIA, GLP, and non-GLP bioanalytical studies placed by assigned clients and championed the establishment of a CLIA program at Tandem Labs. As one of the primary method development chemists, Weslyn was responsible for the method development and validation of endogenous methods for use as biomarkers or in companion diagnostics.
Weslyn graduated from Virginia Tech in 2003 with a BS in Biochemistry, BA in Chemistry, Biochemistry and Organic Chemistry and obtained her PhD in 2008 studying the Molecular Analyses of Melanins and Neuromelanins at Duke University and was a member of the Phi Lambda Upsilon Honor Fraternity.
Susan Fiscus, Ph.D, M.A. Laboratory Director
Dr. Fiscus received a B.S. from Bates College, M.A. from Duke University, and Ph.D. from Colorado State University. Before her retirement in 2014, she was Professor of Microbiology & Immunology and of Pathology & Laboratory Medicine at the University of North Carolina at Chapel Hill, Director of the UNC Clinical Retrovirology Laboratory, and Associate Director of the UNC Center for AIDS Research (CFAR) Virology Core Laboratory. From 2006-2013 she was the Central Laboratory Principal Investigator for the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network. She also served as a member of NIH’s Division of AIDS VQA Quality Assurance Committee, the Adolescent Trials Network DSMB, and as Protocol Virologist for P1077 – Promoting Maternal-Infant Survival Everywhere (PROMISE).
Her research at UNC focused on optimizing methods for the prevention of mother to child transmission of HIV and studying the effects of antiretrovirals and co-infections on the pathogenesis of HIV in compartments by measuring HIV in genital secretions, CSF, saliva, and breast milk. In addition, she evaluated novel methods to diagnose acute HIV infection, early infant diagnostics, and simpler, less expensive ways to monitor response to antiretrovirals in resource limited settings.
Regina Bowling, BSMT(ASCP) Laboratory Manager
Regina J. Bowling BSMT (ASCP) is the Laboratory Manager at Invitrox Technologies, a division of AIDIA Investment Group, Inc. She obtained a BS in Medical Technology from the University of North Carolina at Wilmington and Cape Fear Valley School of Medical Technology in Fayetteville, North Carolina. Regina has over 30 years of technical and supervisory experience with diagnostic, research, development, manufacturing, and CLIA laboratories.
Craig Smitley, B.S. Senior Scientist
Craig Smitley is responsible for overseeing the general laboratory operations of regulated studies conducted for Invitrox Bioanalytical Services. He also assists with LC-MS/MS method development in support of GLP/GCLP/CLIA assays. Mr. Smitley’s past accomplishments include over 30 years of experience executing and/or managing projects involving HPLC or LC/MS analysis of small molecules under GLP, GMP, and/or CLIA regulations. Craig’s past experiences give him time-tested knowledge in the laboratory, which is necessary to effectively meet clients’ requirements of accurate, timely, and high-quality methods for bioanalysis. Mr. Smitley received his bachelor’s degree in Biology with a minor in Chemistry from Mt Vernon University in Mt Vernon, Ohio.